Growth of MIN‐6 Cells on Salmon Fibrinogen Scaffold Improves Insulin Secretion

Abstract

The incidence of type I diabetes has been increasing worldwide at an annual rate of approximately 3%. One of the strategies to treat type I diabetes is islet transplantation, in which dam-aged β‐cells are replaced with new islets. To improve β‐cells’ expansion and pseudoislet formation, studies are focusing on using extracellular‐matrix‐resembling substrates. We evaluated the potential of salmon fibrinogen and chitosan electrospun scaffold as cell substrate for cultivating MIN‐6 cells. The morphology of cells, insulin secretion and gene expression was evaluated and compared with other substrates (nanofibrous scaffold, microporous scaffold and tissue culture polystyrene). We found that all tested 3D conditions favored the pseudoislet formation of MIN‐6 cells. The insulin secretion of MIN‐6 cells after stimulation with high‐glucose media shows approximately a 9‐fold increase compared to the control group when a fibrinogen/chitosan‐based electrospun scaffold was used for cultivation. The differences in insulin secretion were corroborated by differences in gene expression. The differences in insulin secretion could probably be attributed to the differences in the mechanical and/or chemical nature of the tested substrates.